Ron Baron acquired 31.7 Thousand Genmab shares worth $615 Thousand. That's 0.00% of their equity portfolio (276th largest holding). The first Genmab trade was made in Q4 2020. Since then Ron Baron bought shares four more times and sold shares on twelve occasions. The investor's estimated purchase price is $1.18 Million, resulting in a loss of 48%.